Fulcrum Therapeutics Inc (NASDAQ: FULC): Stock Forecast For 2025 Still Looks Weak With A -52.87% Decline
In the last trading session, 1.17 million shares of the Fulcrum Therapeutics Inc (NASDAQ:FULC) were traded, and its beta was 2.48. Most recently the company’s